haloperidol has been researched along with lek 8829 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bole-Vunduk, B; Budihna, MV; Krisch, I; Lavric, B; Ocvirk, A; Pepelnak, M; Sket, D | 1 |
| Sket, D; Sprah, L; Zivin, M | 3 |
4 other study(ies) available for haloperidol and lek 8829
| Article | Year |
|---|---|
Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antipsychotic Agents; Benzazepines; Blood Pressure; Catalepsy; Clozapine; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Lysergic Acid; Male; Mice; Muscarinic Antagonists; Rats; Serotonin Antagonists; Spiperone | 1994 |
The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzazepines; Dose-Response Relationship, Drug; Genes, fos; Haloperidol; Lysergic Acid; Male; Oxidopamine; Pindolol; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1996 |
Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine.
Topics: Animals; Antiparkinson Agents; Benzazepines; Bromocriptine; Dopamine Antagonists; Haloperidol; Lysergic Acid; Male; Motor Activity; Rats; Rats, Wistar; Stereotyped Behavior | 1998 |
Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Bromocriptine; Corpus Striatum; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Haloperidol; Ibotenic Acid; Lysergic Acid; Male; Rats; Rats, Wistar; Receptors, Dopamine; Rotation | 1999 |